Your browser doesn't support javascript.
loading
Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial - ANZGOG 0903.
Mileshkin, Linda; Edmondson, Richard; O'Connell, Rachel L; Sjoquist, Katrin M; Andrews, John; Jyothirmayi, Rema; Beale, Philip; Bonaventura, Tony; Goh, Jeffrey; Hall, Marcia; Clamp, Andrew; Green, John; Lord, Rosemary; Amant, Frédéric; Alexander, Laura; Carty, Karen; Paul, James; Scurry, James; Millan, David; Nottley, Steven; Friedlander, Michael.
Afiliación
  • Mileshkin L; Peter MacCallum Cancer Centre, The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia. Electronic address: Linda.Mileshkin@petermac.org.
  • Edmondson R; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester, UK; Department of Obstetrics and Gynaecology, Manchester Academic Health Science Centre, St Mary's Hospital, Central Manchester NHS Foundation Trust, Manchester Academic He
  • O'Connell RL; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.
  • Sjoquist KM; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.
  • Andrews J; NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.
  • Jyothirmayi R; Maidstone Hospital, Kent, UK.
  • Beale P; Chris O'Brien Lifehouse, Sydney, NSW, Australia.
  • Bonaventura T; Pathology New South Wales, Hunter New England and Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW, Australia.
  • Goh J; Royal Brisbane and Women's Hospital, Brisbane, Australia.
  • Hall M; Mount Vernon Cancer Centre, Middlesex, UK.
  • Clamp A; The Christie NHS Foundation Trust, Manchester, UK.
  • Green J; The Clatterbridge Cancer Centre, Liverpool and Wirral, UK.
  • Lord R; The Clatterbridge Cancer Centre, Liverpool and Wirral, UK.
  • Amant F; Division of Gynecologic Oncology, University Hospitals Gasthuisberg, Leuven, Belgium.
  • Alexander L; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, UK.
  • Carty K; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, UK.
  • Paul J; Cancer Research UK Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, UK.
  • Scurry J; Pathology New South Wales, Hunter New England and Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW, Australia.
  • Millan D; Queen Elizabeth University Hospital, Glasgow, Scotland, UK.
  • Nottley S; Queen Elizabeth University Hospital, Glasgow, Scotland, UK.
  • Friedlander M; Royal Hospital for Women, Prince of Wales Hospital and Prince of Wales Clinical School, University of New South Wales, Sydney, Australia.
Gynecol Oncol ; 154(1): 29-37, 2019 07.
Article en En | MEDLINE | ID: mdl-31130288
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptores de Progesterona / Receptores de Estrógenos / Neoplasias Endometriales / Anastrozol Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Receptores de Progesterona / Receptores de Estrógenos / Neoplasias Endometriales / Anastrozol Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Año: 2019 Tipo del documento: Article